Personalized Therapy and Drug Delivery

Closing Statement: This section is now closed and will no longer accept regular submissions. Ongoing Special Issues will remain open for submission as per their established deadlines.

The “Personalized Therapy and Drug Delivery” Section provides up-to-date reviews and original research on all areas of personalized targeted therapy and immunotherapy. We hope to provide personalized treatment for individual patients or specific patient populations through targeted drug delivery. The Section will cover established, new, and potential drugs, novel therapeutic strategies, machine learning, and cutting-edge technologies employed at all stages of target and drug discovery, validation, delivery, and mechanisms by which drugs may interact with each other and with biological systems.